83 related articles for article (PubMed ID: 10213499)
1. Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells.
Mgbonyebi OP; Russo J; Russo IH
Cancer Res; 1999 Apr; 59(8):1903-10. PubMed ID: 10213499
[TBL] [Abstract][Full Text] [Related]
2. Roscovitine inhibits the proliferative activity of immortal and neoplastic human breast epithelial cells.
Mgbonyebi OP; Russo J; Russo IH
Anticancer Res; 1998; 18(2A):751-5. PubMed ID: 9615715
[TBL] [Abstract][Full Text] [Related]
3. Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.
Goodyear S; Sharma MC
Exp Mol Pathol; 2007 Feb; 82(1):25-32. PubMed ID: 17081516
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo.
Maggiorella L; Deutsch E; Frascogna V; Chavaudra N; Jeanson L; Milliat F; Eschwege F; Bourhis J
Cancer Res; 2003 May; 63(10):2513-7. PubMed ID: 12750274
[TBL] [Abstract][Full Text] [Related]
5. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases.
Bettayeb K; Oumata N; Echalier A; Ferandin Y; Endicott JA; Galons H; Meijer L
Oncogene; 2008 Oct; 27(44):5797-807. PubMed ID: 18574471
[TBL] [Abstract][Full Text] [Related]
6. [Caspase-3 plays a required role in PC12 cell apoptotic death induced by roscovitine].
Gao JX; Zhou YQ; Zhang RH; Ma XL; Liu KJ
Sheng Li Xue Bao; 2005 Dec; 57(6):755-60. PubMed ID: 16344902
[TBL] [Abstract][Full Text] [Related]
7. Roscovitine modulates DNA repair and senescence: implications for combination chemotherapy.
Crescenzi E; Palumbo G; Brady HJ
Clin Cancer Res; 2005 Nov; 11(22):8158-71. PubMed ID: 16299248
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen-activated protein kinase inhibitors.
Maas JW; Horstmann S; Borasio GD; Anneser JM; Shooter EM; Kahle PJ
J Neurochem; 1998 Apr; 70(4):1401-10. PubMed ID: 9523556
[TBL] [Abstract][Full Text] [Related]
9. Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance.
Farahi N; Uller L; Juss JK; Langton AJ; Cowburn AS; Gibson A; Foster MR; Farrow SN; Marco-Casanova P; Sobolewski A; Condliffe AM; Chilvers ER
Clin Exp Allergy; 2011 May; 41(5):673-87. PubMed ID: 21255143
[TBL] [Abstract][Full Text] [Related]
10. Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells.
Wojciechowski J; Horky M; Gueorguieva M; Węsierska-Gądek J
Int J Cancer; 2003 Sep; 106(4):486-495. PubMed ID: 12845642
[TBL] [Abstract][Full Text] [Related]
11. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
Alessi F; Quarta S; Savio M; Riva F; Rossi L; Stivala LA; Scovassi AI; Meijer L; Prosperi E
Exp Cell Res; 1998 Nov; 245(1):8-18. PubMed ID: 9828096
[TBL] [Abstract][Full Text] [Related]
12. The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast cancers.
Cappellini A; Chiarini F; Ognibene A; McCubrey JA; Martelli AM
Cell Cycle; 2009 May; 8(9):1421-5. PubMed ID: 19342873
[TBL] [Abstract][Full Text] [Related]
13. Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.
Abaza MS; Bahman AM; Al-Attiyah RJ
World J Gastroenterol; 2008 Sep; 14(33):5162-75. PubMed ID: 18777593
[TBL] [Abstract][Full Text] [Related]
14. Polyamines modulate the roscovitine-induced cell death switch decision autophagy vs. apoptosis in MCF-7 and MDA-MB-231 breast cancer cells.
Arisan ED; Akkoç Y; Akyüz KG; Kerman EM; Obakan P; Çoker-Gürkan A; Palavan Ünsal N
Mol Med Rep; 2015 Jun; 11(6):4532-40. PubMed ID: 25650699
[TBL] [Abstract][Full Text] [Related]
15. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
Schutte B; Nieland L; van Engeland M; Henfling ME; Meijer L; Ramaekers FC
Exp Cell Res; 1997 Oct; 236(1):4-15. PubMed ID: 9344580
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of cyclin dependent kinases causes p53 dependent apoptosis in renal cell carcinoma.
Ishimaru T; Lau J; Jackson AL; Modiano JF; Weiss RH
J Urol; 2010 Nov; 184(5):2143-9. PubMed ID: 20850841
[TBL] [Abstract][Full Text] [Related]
17. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
18. Prodigiosin induces cell death and morphological changes indicative of apoptosis in gastric cancer cell line HGT-1.
Díaz-Ruiz C; Montaner B; Pérez-Tomás R
Histol Histopathol; 2001 Apr; 16(2):415-21. PubMed ID: 11332697
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human lactoferrin induces apoptosis, disruption of F-actin structure and cell cycle arrest with selective cytotoxicity on human triple negative breast cancer cells.
Iglesias-Figueroa BF; Siqueiros-Cendón TS; Gutierrez DA; Aguilera RJ; Espinoza-Sánchez EA; Arévalo-Gallegos S; Varela-Ramirez A; Rascón-Cruz Q
Apoptosis; 2019 Aug; 24(7-8):562-577. PubMed ID: 30941553
[TBL] [Abstract][Full Text] [Related]
20. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]